Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed or Refractory Diffuse Large B-Cell Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01435720
What this trial is testing

Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL)

Who this might be right for
Multiple MyelomaMultiple Myeloma in RelapseMantle Cell Lymphoma in Relapse+3 more
Senesco Technologies, Inc. 15
Not applicableStudy completedNCT00856388
What this trial is testing

Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+97 more
Roswell Park Cancer Institute 62
Testing effectiveness (Phase 2)Study completedNCT00062296
What this trial is testing

Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphoma
Fox Chase Cancer Center 5
Testing effectiveness (Phase 2)Study completedNCT02226965
What this trial is testing

PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)

Who this might be right for
Lymphoma, Diffuse Large B-Cell
Sierra Oncology LLC - a GSK company 45
Testing effectiveness (Phase 2)Ended earlyNCT02361346
What this trial is testing

Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL

Who this might be right for
Non-Hodgkin's B-cell LymphomaLeukemia, Lymphocytic, Chronic, B-CellSmall Lymphocytic Leukemia+3 more
Molecular Templates, Inc. 38
Testing effectiveness (Phase 2)WithdrawnNCT04456023
What this trial is testing

Study of Tisagenlecleucel in Chinese Adult Patients With Relapsed or Refractory Diffuse Large B-cell Non-Hodgkin Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B-Cell Lymphoma (DLBCL)
Novartis Pharmaceuticals
Not applicableLooking for participantsNCT06299553
What this trial is testing

Study to Evaluate the Effectiveness of Tafasitamab in Combination With Lenalidomide Followed by Tafasitamab Monotherapy in Relapsed or Refractory Diffuse Large B-cell Lymphoma Non-transplant Eligible Patients in Italy (PRO-MIND)

Who this might be right for
DLBCL - Diffuse Large B Cell Lymphoma
Incyte Biosciences Italy S.r.l 200
Not applicableStudy completedNCT04981795
What this trial is testing

RealMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL

Who this might be right for
Diffuse Large B-cell Lymphoma
Incyte Corporation 102
Testing effectiveness (Phase 2)Study completedNCT01177371
What this trial is testing

High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+70 more
Case Comprehensive Cancer Center 13
Not applicableStudy completedNCT00098566
What this trial is testing

Long-Term Effects of Iodine I Tositumomab and Autologous Bone Marrow or Stem Cell Transplantation in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
LymphomaQuality of Life
Fred Hutchinson Cancer Center 36
Testing effectiveness (Phase 2)Ended earlyNCT03422523
What this trial is testing

Atezolizumab, Rituximab, Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory DLBCL Not Suitable for High-dose Therapy

Who this might be right for
Diffuse Large B Cell LymphomaRelapsed Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma
University Hospital Southampton NHS Foundation Trust 53
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07713459
What this trial is testing

A Phase II Study to Evaluate the Efficacy of UF-KURE19 Cells in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

Who this might be right for
Lymphoma NonhodgkinMarginal Zone B Cell LymphomaDiffuse Large B Cell Lymphoma (DLBCL)+2 more
Kure Cells, INC 105
Early research (Phase 1)Ended earlyNCT05169489
What this trial is testing

BbT369 in Relapsed and/or Refractory B Cell Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Diffuse Large B Cell Lymphoma (DLBCL)
Regeneron Pharmaceuticals 15
Testing effectiveness (Phase 2)Study completedNCT00002982
What this trial is testing

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Older Patients With Refractory or Relapsed Intermediate-Grade Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT04432506
What this trial is testing

Anakinra for the Reduction of CAR-T Toxicity in Patients With Relapsed or Refractory Large B-cell Lymphoma

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmRecurrent Diffuse Large B-Cell LymphomaRecurrent High Grade B-Cell Lymphoma+6 more
M.D. Anderson Cancer Center 22
Early research (Phase 1)Study completedNCT02374333
What this trial is testing

Pilot Study of Redirected Autologous T Cells Engineered to Contain Humanized Anti-CD19 in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma Previously Treated With Cell Therapy

Who this might be right for
Acute Lymphocytic LeukemiaDiffuse Large Cell Lymphoma
University of Pennsylvania 81
Testing effectiveness (Phase 2)WithdrawnNCT00776802
What this trial is testing

GCS-100LE in Combination With Etoposide and Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
La Jolla Pharmaceutical Company
Not applicableStudy completedNCT00445731
What this trial is testing

A Structured Walking Program or Standard Therapy in Cancer Patients Undergoing a Donor Bone Marrow Transplant

Who this might be right for
Cancer
University of Minnesota 115
Testing effectiveness (Phase 2)Study completedNCT00003887
What this trial is testing

Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center
Not applicableStudy completedNCT00453206
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
Wake Forest University Health Sciences 66
Next Page